331 related articles for article (PubMed ID: 17333105)
21. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway.
Zhou G; Li C; Cai L
Am J Pathol; 2004 Dec; 165(6):2033-43. PubMed ID: 15579446
[TBL] [Abstract][Full Text] [Related]
22. Comparison of prostaglandin F2alpha, bimatoprost (prostamide), and butaprost (EP2 agonist) on Cyr61 and connective tissue growth factor gene expression.
Liang Y; Li C; Guzman VM; Evinger AJ; Protzman CE; Krauss AH; Woodward DF
J Biol Chem; 2003 Jul; 278(29):27267-77. PubMed ID: 12724323
[TBL] [Abstract][Full Text] [Related]
23. Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia.
Gellhaus A; Schmidt M; Dunk C; Lye SJ; Kimmig R; Winterhager E
Mol Hum Reprod; 2006 Jun; 12(6):389-99. PubMed ID: 16675545
[TBL] [Abstract][Full Text] [Related]
24. Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts.
Twigg SM; Joly AH; Chen MM; Tsubaki J; Kim HS; Hwa V; Oh Y; Rosenfeld RG
Endocrinology; 2002 Apr; 143(4):1260-9. PubMed ID: 11897682
[TBL] [Abstract][Full Text] [Related]
25. Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance.
Zeng ZJ; Yang LY; Ding X; Wang W
World J Gastroenterol; 2004 Dec; 10(23):3414-8. PubMed ID: 15526358
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression.
Li J; Gao X; Ji K; Sanders AJ; Zhang Z; Jiang WG; Ji J; Ye L
Oncol Rep; 2016 Nov; 36(5):2517-2525. PubMed ID: 27633176
[TBL] [Abstract][Full Text] [Related]
27. The CCN family: a new stimulus package.
Brigstock DR
J Endocrinol; 2003 Aug; 178(2):169-75. PubMed ID: 12904165
[TBL] [Abstract][Full Text] [Related]
28. Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.
Makino H; Mukoyama M; Sugawara A; Mori K; Suganami T; Yahata K; Fujinaga Y; Yokoi H; Tanaka I; Nakao K
Clin Exp Nephrol; 2003 Mar; 7(1):33-40. PubMed ID: 14586741
[TBL] [Abstract][Full Text] [Related]
29. Muscarinic acetylcholine receptors induce the expression of the immediate early growth regulatory gene CYR61.
Albrecht C; von Der Kammer H; Mayhaus M; Klaudiny J; Schweizer M; Nitsch RM
J Biol Chem; 2000 Sep; 275(37):28929-36. PubMed ID: 10852911
[TBL] [Abstract][Full Text] [Related]
30. Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis.
Croci S; Landuzzi L; Nicoletti G; Palladini A; Antognoli A; De Giovanni C; Nanni P; Lollini PL
Pathol Oncol Res; 2007; 13(4):336-9. PubMed ID: 18158569
[TBL] [Abstract][Full Text] [Related]
31. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease.
Burns WC; Twigg SM; Forbes JM; Pete J; Tikellis C; Thallas-Bonke V; Thomas MC; Cooper ME; Kantharidis P
J Am Soc Nephrol; 2006 Sep; 17(9):2484-94. PubMed ID: 16914537
[TBL] [Abstract][Full Text] [Related]
32. Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa x tissue factor-induced signal transduction.
Pendurthi UR; Allen KE; Ezban M; Rao LV
J Biol Chem; 2000 May; 275(19):14632-41. PubMed ID: 10799550
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas.
Sampath D; Zhu Y; Winneker RC; Zhang Z
J Clin Endocrinol Metab; 2001 Apr; 86(4):1707-15. PubMed ID: 11297607
[TBL] [Abstract][Full Text] [Related]
34. The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-β signaling.
Borkham-Kamphorst E; Schaffrath C; Van de Leur E; Haas U; Tihaa L; Meurer SK; Nevzorova YA; Liedtke C; Weiskirchen R
Biochim Biophys Acta; 2014 May; 1843(5):902-14. PubMed ID: 24487063
[TBL] [Abstract][Full Text] [Related]
35. Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitus.
Twigg SM; Chen MM; Joly AH; Chakrapani SD; Tsubaki J; Kim HS; Oh Y; Rosenfeld RG
Endocrinology; 2001 May; 142(5):1760-9. PubMed ID: 11316739
[TBL] [Abstract][Full Text] [Related]
36. Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis.
Koitabashi N; Arai M; Kogure S; Niwano K; Watanabe A; Aoki Y; Maeno T; Nishida T; Kubota S; Takigawa M; Kurabayashi M
Hypertension; 2007 May; 49(5):1120-7. PubMed ID: 17372041
[TBL] [Abstract][Full Text] [Related]
37. [Progress in the study of CCN family].
Su BY; Cai WQ
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):179-83. PubMed ID: 12390824
[TBL] [Abstract][Full Text] [Related]
38. Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions.
Schober JM; Chen N; Grzeszkiewicz TM; Jovanovic I; Emeson EE; Ugarova TP; Ye RD; Lau LF; Lam SC
Blood; 2002 Jun; 99(12):4457-65. PubMed ID: 12036876
[TBL] [Abstract][Full Text] [Related]
39. CCN proteins: multifunctional signalling regulators.
Perbal B
Lancet; 2004 Jan; 363(9402):62-4. PubMed ID: 14723997
[TBL] [Abstract][Full Text] [Related]
40. Regeneration of defects in articular cartilage in rat knee joints by CCN2 (connective tissue growth factor).
Nishida T; Kubota S; Kojima S; Kuboki T; Nakao K; Kushibiki T; Tabata Y; Takigawa M
J Bone Miner Res; 2004 Aug; 19(8):1308-19. PubMed ID: 15231019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
